Contineum Therapeutics (CTNM) Institutional Ownership $7.59 -0.31 (-3.92%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$7.90 +0.31 (+4.14%) As of 02/21/2025 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Contineum Therapeutics (NASDAQ:CTNM)Number ofInstitutional Buyers(last 12 months)34TotalInstitutional Inflows(last 12 months)$130.04MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$12.10M Get CTNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Contineum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CTNM Institutional Buying and Selling by Quarter Contineum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC217,239$3.18M0.0%-37.9%0.843% 2/17/2025 Stempoint Capital LP265,833$3.89M1.0%N/A1.031% 2/17/2025 Red Tree Management LLC638,158$9.35M6.2%N/A2.475% 2/17/2025 Polar Capital Holdings Plc43,604$639K0.0%-79.9%0.169% 2/17/2025 Nuveen Asset Management LLC13,307$195K0.0%N/A0.052% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,860$86K0.0%+90.4%0.023% 2/17/2025 Janus Henderson Group PLC68,320$1.00M0.0%N/A0.265% 2/17/2025 Deutsche Bank AG16,079$236K0.0%N/A0.062% 2/17/2025 Bank of America Corp DE9,132$134K0.0%+63.4%0.035% 2/14/2025 Schonfeld Strategic Advisors LLC125,995$1.85M0.0%N/A0.489% Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025 Northern Trust Corp89,262$1.31M0.0%+42.3%0.346% 2/14/2025 MetLife Investment Management LLC7,029$103K0.0%N/A0.027% 2/14/2025 Altium Capital Management LLC334,000$4.89M1.4%-9.5%1.296% 2/13/2025 Marshall Wace LLP10,836$159K0.0%N/A0.042% 2/13/2025 Strategies Wealth Advisors LLC25,000$366K0.0%N/A0.097% 2/13/2025 Barclays PLC16,286$239K0.0%+96.0%0.063% 2/13/2025 Legal & General Group Plc3,631$53K0.0%+74.0%0.014% 2/13/2025 ADAR1 Capital Management LLC82,234$1.21M0.2%+817.1%0.319% 2/13/2025 Wells Fargo & Company MN10,755$158K0.0%+419.3%0.042% 2/12/2025 Geode Capital Management LLC188,408$2.76M0.0%+46.4%0.731% 2/12/2025 Franklin Resources Inc.1,445,565$21.18M0.0%-0.1%5.607% 2/12/2025 Norges Bank169,729$2.49M0.0%N/A0.658% 2/12/2025 JPMorgan Chase & Co.28,426$416K0.0%+1,040.7%0.110% 2/12/2025 WINTON GROUP Ltd39,738$582K0.0%+256.8%0.154% 2/11/2025 Corebridge Financial Inc.5,215$76K0.0%+73.1%0.020% 2/6/2025 Charles Schwab Investment Management Inc.55,330$811K0.0%+27.8%0.215% 2/4/2025 Bank of New York Mellon Corp18,738$275K0.0%+32.3%0.073% 1/30/2025 Rhumbline Advisers8,233$121K0.0%+36.3%0.032% 11/27/2024 Franklin Resources Inc.1,447,550$27.71M0.0%+130.9%5.615% 11/19/2024 Barclays PLC8,308$158K0.0%+248.6%0.032% 11/16/2024 Geode Capital Management LLC128,676$2.46M0.0%-17.7%0.500% 11/15/2024 Barclays PLC8,308$158K0.0%+248.6%0.032% 11/15/2024 State Street Corp113,566$2.17M0.0%+23.7%0.442% 11/14/2024 Suvretta Capital Management LLC1,720,000$32.92M1.1%-16.2%6.687% 11/13/2024 BNP Paribas Financial Markets6,743$129K0.0%+1,248.6%0.026% 11/13/2024 FMR LLC696,927$13.34M0.0%+115.4%2.710% 11/12/2024 Charles Schwab Investment Management Inc.43,295$829K0.0%-16.4%0.168% 8/16/2024 Perceptive Advisors LLC1,566,668$27.59M0.7%N/A6.091% 8/16/2024 Driehaus Capital Management LLC66,667$1.17M0.0%N/A0.259% 8/14/2024 Squarepoint Ops LLC150,000$2.64M0.0%N/A0.583% Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y8/14/2024 Sandia Investment Management LP5,000$88K0.1%N/A0.019% 8/9/2024 Johnson & Johnson1,979,173$34.85M8.7%N/A7.694% 8/8/2024 Versant Venture Management LLC918,163$16.17M20.9%N/A3.569% 8/1/2024 Rhumbline Advisers6,722$118K0.0%N/A0.026% 7/26/2024 Bank of New York Mellon Corp20,232$356K0.0%N/A0.079% (Data available from 1/1/2016 forward) CTNM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CTNM shares? During the previous two years, 37 institutional investors and hedge funds held shares of Contineum Therapeutics. The most heavily invested institutionals were Johnson & Johnson ($34.85M), Suvretta Capital Management LLC ($32.92M), Perceptive Advisors LLC ($27.59M), Franklin Resources Inc. ($21.18M), Versant Venture Management LLC ($16.17M), FMR LLC ($13.34M), and Red Tree Management LLC ($9.35M).Learn more on CTNM's institutional investors. Which institutional investors have been buying Contineum Therapeutics stock? Of the 34 institutional investors that purchased Contineum Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Johnson & Johnson ($1.98M), Perceptive Advisors LLC ($1.57M), Versant Venture Management LLC ($918.16K), Franklin Resources Inc. ($820.54K), Red Tree Management LLC ($638.16K), FMR LLC ($373.33K), and Stempoint Capital LP ($265.83K). How much institutional buying is happening at Contineum Therapeutics? Institutional investors have bought a total of 7,546,245 shares in the last 24 months. This purchase volume represents approximately $130.04M in transactions. Which Contineum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Contineum Therapeutics stock in the last 24 months: Suvretta Capital Management LLC ($333.33K), Polar Capital Holdings Plc ($173.00K), Squarepoint Ops LLC ($132.76K), Altium Capital Management LLC ($35.13K), Geode Capital Management LLC ($27.75K), Charles Schwab Investment Management Inc. ($8.48K), and Franklin Resources Inc. ($1.99K). How much institutional selling is happening at Contineum Therapeutics? Institutional investors have sold a total of 712,425 shares in the last 24 months. This volume of shares sold represents approximately $12.10M in transactions. Related Companies CVAC Institutional Ownership EOLS Institutional Ownership BCYC Institutional Ownership CDMO Institutional Ownership ORIC Institutional Ownership DNA Institutional Ownership NUVB Institutional Ownership PRTA Institutional Ownership OPT Institutional Ownership CRON Institutional Ownership This page (NASDAQ:CTNM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTNM Stock Alerts